Hiring reps - coast to coast expansion

Quote


















Anonymous said:
Really, No Really. To sell what OTC Fish Oil......Get A Real Job
Click to expand...
Actually if you were to compare OTC fish oil to both Vascepa and Lovaza, L would be more like the OTC fish oil. And, Lovaza generates how much revenue per year for GSK? AMRN will take a big piece of that market from GSK...and it's a big market.
Are you here on behalf of the OTC fish oil industry? Did they contract with your employer to send you monkeys to bash? I'm sure they did.
 






Anonymous said:
Actually if you were to compare OTC fish oil to both Vascepa and Lovaza, L would be more like the OTC fish oil. And, Lovaza generates how much revenue per year for GSK? AMRN will take a big piece of that market from GSK...and it's a big market.
Are you here on behalf of the OTC fish oil industry? Did they contract with your employer to send you monkeys to bash? I'm sure they did.
Click to expand...

You seem to equate science with sales. Please let me introduce you to the stock market. Here, money is power and Amarin is broke.
 






Anonymous said:
You seem to equate science with sales. Please let me introduce you to the stock market. Here, money is power and Amarin is broke.
Click to expand...

again, you're apparently not equipped for the conversation. You keep saying AMRN is broke...so we're all ears on how you came up with that. Tell us how AMRN is broke?
Do you know how much cash is on hand? Do you know the cash burn rate and how the launch impacted Q1 vs what we should anticipate in Q2? Have you run forecast models on the current script growth and what the revenue generation looks like going into the end of the year.... and how that will slow cash burn? Of course not... you just have these uninformed generic responses because that's all you're equipped to offer. You're just not very smart.
 






Anonymous said:
again, you're apparently not equipped for the conversation. You keep saying AMRN is broke...so we're all ears on how you came up with that. Tell us how AMRN is broke?
Do you know how much cash is on hand? Do you know the cash burn rate and how the launch impacted Q1 vs what we should anticipate in Q2? Have you run forecast models on the current script growth and what the revenue generation looks like going into the end of the year.... and how that will slow cash burn? Of course not... you just have these uninformed generic responses because that's all you're equipped to offer. You're just not very smart.
Click to expand...

We are speaking in relative terms. Apparently you cannot differentiate between a Goliath in GSK, PFE, MRK, etc and an amoeba in AMRN. If you sell the rights to your entire company for a $150M loan, then you cannot compete against the guys with +100B market caps. Money is more important than science here. This is a financial market.
 






Anonymous said:
We are speaking in relative terms. Apparently you cannot differentiate between a Goliath in GSK, PFE, MRK, etc and an amoeba in AMRN. If you sell the rights to your entire company for a $150M loan, then you cannot compete against the guys with +100B market caps. Money is more important than science here. This is a financial market.
Click to expand...

Money more important than science?
This is not a financial board.
We are in the healthcare industry,not money grubbers of Wall Street. Get the hell off the board, go back to Yahoo you ass. Your response speaks volumes...
 




































Anonymous said:
again, you're apparently not equipped for the conversation. You keep saying AMRN is broke...so we're all ears on how you came up with that. Tell us how AMRN is broke?
Do you know how much cash is on hand? Do you know the cash burn rate and how the launch impacted Q1 vs what we should anticipate in Q2? Have you run forecast models on the current script growth and what the revenue generation looks like going into the end of the year.... and how that will slow cash burn? Of course not... you just have these uninformed generic responses because that's all you're equipped to offer. You're just not very smart.
Click to expand...

Youre right. Not broke but here is the realty. You will sell roughly 7-10 million in q2. Lets assume 20% cogs and you will recognize 6-7 million in GP for the quarter. I will also assume 20% rebates so realistically 5 million in net sales. You have cash of 200 mil, and SGA costs of 40 mil per quarter- most of it the sales force and 20 mil a quarter for research and development. If all is applied, you will lose an additional 55 million in cash this quarter down to 150. You have debt commitments of almost 300 million that costs 8 million a quarter in cash so now were at 142 with a burn rate of ~60 million a quarter. Now sales will increase. My guess is 30% each quarter so the burn will slow by about 3-5 million, but still a 50 million burn per quarter. You have about 2 quarters left before you either a- refinance, b- cut sales costs c-renegotiate debt 4-Get sold.

Just one persons humble opinion
 












Anonymous said:
Youre right. Not broke but here is the realty. You will sell roughly 7-10 million in q2. Lets assume 20% cogs and you will recognize 6-7 million in GP for the quarter. I will also assume 20% rebates so realistically 5 million in net sales. You have cash of 200 mil, and SGA costs of 40 mil per quarter- most of it the sales force and 20 mil a quarter for research and development. If all is applied, you will lose an additional 55 million in cash this quarter down to 150. You have debt commitments of almost 300 million that costs 8 million a quarter in cash so now were at 142 with a burn rate of ~60 million a quarter. Now sales will increase. My guess is 30% each quarter so the burn will slow by about 3-5 million, but still a 50 million burn per quarter. You have about 2 quarters left before you either a- refinance, b- cut sales costs c-renegotiate debt 4-Get sold.

Just one persons humble opinion
Click to expand...

This is spot on. I think joe is clearly looking to reduce sales costs. Look at the compliance memos that just went out.
 






Anonymous said:
Youre right. Not broke but here is the realty. You will sell roughly 7-10 million in q2. Lets assume 20% cogs and you will recognize 6-7 million in GP for the quarter. I will also assume 20% rebates so realistically 5 million in net sales. You have cash of 200 mil, and SGA costs of 40 mil per quarter- most of it the sales force and 20 mil a quarter for research and development. If all is applied, you will lose an additional 55 million in cash this quarter down to 150. You have debt commitments of almost 300 million that costs 8 million a quarter in cash so now were at 142 with a burn rate of ~60 million a quarter. Now sales will increase. My guess is 30% each quarter so the burn will slow by about 3-5 million, but still a 50 million burn per quarter. You have about 2 quarters left before you either a- refinance, b- cut sales costs c-renegotiate debt 4-Get sold.

Just one persons humble opinion
Click to expand...

Good post. My guess is a combination of a secondary offering (dilution of shares) along with expense reductions. Sales goals for reps will be mostly out of reach in order to keep bonuses low and preserve a bit of the cash.

Eventually, the company will be sold on the cheap to a company with a sales force that already has the embedded cost in their current infrastructure.
 






I keep hearing rumors about Pfizer buying Amarin. If that is true, I am already going to go out and find a new job before that abortion of a company swallows us up. I would rather clean the augean stables with my own toothbrush than work for Pfizer
 






Anonymous said:
I keep hearing rumors about Pfizer buying Amarin. If that is true, I am already going to go out and find a new job before that abortion of a company swallows us up. I would rather clean the augean stables with my own toothbrush than work for Pfizer
Click to expand...

The only place I hear about buyout rumors are on message boards. I wouldn't worry about them.
 






Anonymous said:
I keep hearing rumors about Pfizer buying Amarin. If that is true, I am already going to go out and find a new job before that abortion of a company swallows us up. I would rather clean the augean stables with my own toothbrush than work for Pfizer
Click to expand...

I don't think we will be working for Pfizer if they buy Amarin, so that's one thing you don't have to worry about!
 






Top Bottom
Back
Quote